Collaboration with Allergan is first exploratory application of technology, in NASH
“Today, liver biopsy is the gold standard used to diagnose NASH—the fastest growing liver disease worldwide—and to evaluate potential new treatments to reverse its course. Virtual Stainer gives us a unique opportunity to evaluate the richness of information available in liver tissue acquired through biopsy, well beyond currently available staining and imaging technologies,” says Dr. Laurent Fischer, Head of Liver Therapeutic Area at Allergan.